Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating two dose levels of Purified Cortrophin Gel for efficacy and safety in patients with acute gout flares; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Purified Cortrophin Gel (repository corticotropin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Gout Arthritis, Gout Flare | Phase 4 | Status: RECRUITING